Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tongluo Mingmu Capsule for Non‑Proliferative Diabetic Retinopathy
ChiCTR2600118638Phase 4Not yet recruiting
- Sponsor
- The First Affiliated Hospital of Harbin Medical University
- Start
- Feb 2026
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in nonproliferative diabetic retinopathy (NPDR) comparing Tongluo Mingmu Capsule with Placebo (2 arms). Primary endpoint: DRSS grade at week 24. Planned start Feb 2026; status: not yet recruiting.
02
Drugs
Tongluo Mingmu Capsule
03
Conditions
nonproliferative diabetic retinopathy (NPDR)
Beyond the preview
Go deeper on ChiCTR2600118638.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2600118638.